Valery Krasnoperov
Chief Tech/Sci/R&D Officer presso HALO COLLECTIVE INC.
Profilo
Valery Krasnoperov is currently the Chief Scientific Officer at Halo Collective, Inc. Prior to this, he worked as the Director of Research & Development at VasGene Therapeutics, Inc. He also worked as a Research Scientist at New York University and The University of Nottingham.
Posizioni attive di Valery Krasnoperov
Società | Posizione | Inizio |
---|---|---|
HALO COLLECTIVE INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Valery Krasnoperov
Società | Posizione | Fine |
---|---|---|
New York University | Corporate Officer/Principal | - |
The University of Nottingham | Corporate Officer/Principal | - |
VasGene Therapeutics, Inc.
VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Chief Tech/Sci/R&D Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HALO COLLECTIVE INC. | Process Industries |
Aziende private | 1 |
---|---|
VasGene Therapeutics, Inc.
VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Commercial Services |
- Borsa valori
- Insiders
- Valery Krasnoperov